Abstract
Purpose of Review
Telemedicine and digital health platforms are now integral to the way patients and clinicians interact with the health system. Application of these technologies in the antepartum context is well studied and accepted. The purpose of this review is to outline the state of telemedicine and digital health solutions in the intrapartum and postpartum period, understanding applications for labor and the months following delivery.
Recent Findings
Telemedicine can be used in the intrapartum period to assist with staffing shortages, remote assessment of intrapartum fetal heart tracings, and doula support. Application in the postpartum period includes but is not limited to remote blood pressure monitoring, lactation support, mental health screening and treatment, and substance use disorder.
Summary
Both telemedicine and digital health solutions aim to augment, not replace, care relationship during pregnancy, delivery, and postpartum. Whether these tools advance intrapartum and postpartum care remains subject to the same contingencies present in other specialties and care contexts. Ongoing investment into the application and evaluation of telemedicine and digital health solutions throughout pregnancy should be prioritized.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Once novel technologies in the care delivery space, telemedicine and digital health platforms are now integral to the way patients and clinicians interact with the health system. The COVID-19 pandemic spawned—out of necessity—a rapid and widespread adoption of these technologies across specialties and care contexts. In one assessment comparing ambulatory encounters in a large commercially insured cohort, telehealth visits went from accounting for less than 0.5% of billable interactions in 2019 to 24% in 2020 [1]. That trend persisted, even as the pandemic waned: 87% of physicians reported using telemedicine to deliver care in 2021, compared with less than 20% in 2019 [2•]. Compared with the traditional in-person care model, there are many theoretical advantages to delivering pregnancy care remotely for patients and clinicians alike in the way of expanded care access, increased patient satisfaction, lower care costs, and enhanced personal health data collection [3••]. Still, these advantages are only virtuous insofar as care quality and health equity are upheld or bolstered in the process [4••].
There is a significant literature to date examining the application of these technologies to the care of pregnant patients, with an emphasis on the antepartum context [5, 6, 7•, 8•]. This focus on the prenatal period is sensible for clinicians, researchers, and commercial stakeholders, both because it encompasses the longest portion of the pregnancy episode and contains the most individual care interactions with the patient. This should not, however, undermine the importance of applying and evaluating telemedicine and digital health platforms for labor and delivery, and for maternal health in the months that follow. Here, we review the state of telemedicine and digital health solutions applied to the intrapartum and postpartum period.
Intrapartum Care
While contemporary applications of telemedicine often occur in the outpatient space, it is important to recall that several specialties tested and adopted inpatient telemedicine long before the recent wave of pandemic-spurred digital health technology. Telemedicine for acute stroke management—referred to more commonly as “telestroke”– emerged a quarter century ago, with remote neurologists evaluating patients experiencing acute strokes and guiding time-sensitive management decisions, such as whether to administer thrombolytic therapy. Implementation of these programs has been associated with improvements in several care quality and outcome indicators [9]. Likewise, intensive care units (ICUs) have long adopted telemedicine models to ease intensivist staffing constraints. Though research prior to the pandemic on the value of these models produced mixed results [10], teleICU became instrumental in supporting hospitals with a limited intensivist presence during the COVID 19 pandemic [11].
To date, the literature is sparse when it comes to implementation of telemedicine programs for inpatient obstetrics, and as a result little is known about the potential for telemedicine to impact maternal morbidity and mortality in units with limited in-person staffing for routine obstetric care (to say nothing of maternal-fetal medicine and critical care obstetrics). This is of particular concern against the backdrop of widespread obstetric service closures and rural staffing challenges, giving rise to maternity care deserts [12•]. While more than half of births in the US take place at high-volume obstetric hospitals (i.e., those with 2,000 deliveries or more per year), more than a third of all units are classified as low volume (i.e., those with 10–500 births per year). Among low volume units, only a quarter are within 30 miles of a high-volume obstetric hospital [13], a practical barrier to the timely transfer of acute patients requiring a higher level of care. Recently, the Mayo Clinic published a report on the provision of telemedicine obstetric hospitalist services to 17 low-resource hospitals across two states. The “TeleOB” program is staffed by obstetric hospitalists physically located in a tertiary medical center and uses on-demand high-definition audio and video to support clinicians at the remote site. 25 site activations have been completed to date: 17 deliveries, two postpartum consultations, and four antepartum consultations. 80% of these activations occurred at sites without maternity services and in most of the deliveries, tele-neonatology was jointly activated to guide resuscitation efforts [14••]. Recently, others in the literature have reported on the use of a digital platform for the remote assessment of intrapartum fetal heart tracings across multiple labor units, though a formal, published assessment of outcomes is still forthcoming [15]. In England, one small qualitative study of home inductions of labor suggests remote intrapartum fetal monitoring is acceptable and may be preferable for those laboring, though again, assessment of outcomes remains limited [16]. Significant strides are being made in the application of remote fetal monitoring [17••, 18•] and patient-operated ultrasound [19•, 20] to antepartum surveillance; these technologies may extend to intrapartum care in the future, but at least for now falls outside the scope of this review. The need for more implementation and health services research into this underexplored area of intrapartum care cannot be overstated.
Birthing patients have benefited from other digital technologies aimed at empowerment in the intrapartum period. Doula care, until recently an in-person-only service, is now offered in many parts of the country as a virtual service across pregnancy, including the intrapartum period [21••]. One study examining the impact of virtual doula services demonstrated lower rates of cesarean section and higher rates of personal satisfaction with the labor process among patients using a virtual doula platform. In a sub-analysis of users who identify as Black, platform use was associated with a significantly higher rate of vaginal birth after cesarean (VBAC) [22••]. Beyond direct care delivery, several studies have evaluated the impact of smartphone app-enabled educational tools on patient-centered and clinical outcomes [23•, 24]. Cai and colleagues recently published a randomized controlled trial evaluating the impact of a labor-focused podcast series on pregnant patients in the third trimester. Those randomized to the podcast intervention were more likely to report higher levels of personal satisfaction following labor; among the subgroup of patients who underwent induction of labor, labor agentry scores were significantly higher in the podcast group [23•]. Though not yet the subject of peer-reviewed research, digital patient review platforms for birthing units and clinicians are becoming important tools for patient empowerment. Irth, for example, is a review and rating platform for patients who identify as Black or brown to publish their care experiences. The platform aims to support birthing people and new parents in care selection and to provide health systems with candid feedback to promote anti-racist care practices.
Postpartum Care
Historically, postpartum health has received an unacceptable lack of attention from society, including the medical community. To quote Dr. Kristin Tully and Dr. Allison Stuebe, “It is as though the baby is the candy, and the mother is the wrapper. After the candy is out, the wrapper is cast aside” [25•]. This is no less evident in the focus of smartphone application developers, at least in the published literature prior to the pandemic. In a systematic review of mobile health applications for postnatal care published at the start of 2019, researchers counted 48 postnatal applications available for download on the iOS and Android repositories. As might be suggested by the word “postnatal”, the authors analyses show that while all 48 apps contained content on care for the neonate, most overlooked content on care for the parent [26]. Since that time, maternal health in the postpartum period has garnered increasing attention from researchers, policy makers [27], and commercial interests, particularly as epidemiologic data have demonstrated that most maternal mortality occurs long after delivery [28•]. Telemedicine and digital health platforms are necessary components in a multifaceted approach to stem avoidable maternal harm and eliminate racial disparities therein. If implemented thoughtfully, they have the capacity to expand care access to those that are, concomitantly, the most in need of care and the most at risk for adverse outcomes in the postpartum period [4••].
The shift to telemedicine through the pandemic produced a natural experiment in care access across specialties. Postpartum visits—erstwhile singular, poorly attended, in-person-only office visits six weeks after delivery—were suddenly occurring through telemedicine or video chat platforms. The postpartum period, more so than its prenatal counterpart, introduces barriers to accessing legacy in-person care for reasons that are self-evident; one might hypothesize, then, enhanced access to care following the shift to postpartum telemedicine. In one retrospective study conducted during the pandemic, researchers found that the availability of a telemedicine option was associated with higher rates of postpartum visit attendance and postpartum depression screening [29•]. This same period, however, was also associated with lower rates of uptake for long-acting reversible contraception (LARC) and permanent sterilization—more likely a consequence of the pandemic rather than the advent of telemedicine. Furthermore, Kumar and colleagues demonstrated a significant decrease in racial disparities in postpartum visit attendance following telehealth implementation, as well as in postpartum depression screening [30•]. While far from conclusive, this suggests a role for telemedicine as a lever to increase postpartum care access, particularly for those likely to face outsize barriers to care from the start.
The surveillance and treatment of postpartum hypertension is perhaps the best studied example of condition-specific telemedicine implementation in the postpartum period. Post-delivery remote blood pressure monitoring programs use a smartphone application or text message-based platform to prompt patients to obtain and submit blood pressures at defined intervals during the postpartum period. When a blood pressure reading is flagged as abnormal, the program routes it to a clinician for review and further management. The value of these programs in patients with postpartum hypertension includes increased ascertainment of blood pressure readings compared to controls and a significantly lower risk of adverse maternal outcomes in the first six months following delivery among those enrolled [31, 32, 33••]. Likewise, remote blood pressure monitoring programs enable large scale data collection, with enough heft to support instrumental analyses of blood pressures trajectories following delivery and to identify racial disparities in hypertension management across the postpartum period [34•, 35]. Similarly, blood glucose monitoring in patients with gestational or pregestational diabetes has long been the subject of research on digital health interventions to improve maternal and perinatal outcomes. Most of the recent literature focuses on antepartum glucose management with continuous glucose monitoring (CGM) devices [36•, 37, 38]. This falls outside the scope of the current manuscript and, we argue, deserves a dedicated review of its own.
Other emerging telemedicine and smartphone applications target specific aspects of routine postpartum care. Lactation support represents one example, with mixed results in the literature to date. A randomized trial among approximately 200 patients planning to feed by lactation examined the effects of a smartphone-based platform on rates of lactation over time. Users of the platform, which provided daily feedback and counseling from a multidisciplinary lactation team, showed higher rates of lactation at six and twelve weeks compared to controls [39••]. In a separate trial powered to detect differences in breastfeeding initiation, 170 low-income, primiparous patients were randomized to a curated smartphone app containing on-demand education and videos compared to a control application with digital breastfeeding handouts. Neither intervention improved breastfeeding rates above known baseline rates, with no differences between groups [40]. A secondary analysis assessed rates of breastfeeding initiation in each group stratified by app usage; however, increased usage was not associated with higher rates of breastfeeding in either group [41].
The treatment of maternal mental health and substance use disorder (OUD) warrants considerable national attention, particularly considering each condition’s alarming contribution to the preventable pregnancy-related death rate [42, 43•]. Recent data surrounding the detection and management of postpartum depression through telemedicine and digital health solutions offer some encouragement. A 2020 systematic review and metanalysis included 11 studies focused on a mobile health intervention for the prevention and treatment of postpartum depression. Subgroup analyses were planned for telephone-based and smartphone application-based interventions, as well as for those focused on prevention versus those focused on treatment. Overall, the metanalysis suggests that telephone and smartphone application-based interventions were each associated with a statistically significant improvement in the prevention and treatment of postpartum depression, with no significant heterogeneity among studies and no significant difference in the result after sensitivity analyses [44]. More recently, a large randomized controlled trial was conducted in Japan to assess the impact of internet-delivered cognitive behavioral therapy (iCBT) for the prevention of postpartum depression. Over 5,000 pregnant individuals were randomized in the midtrimester to either iCBT or general health information and assessed for major depression at 32 weeks and 3 months postpartum. There was no difference in rates of perinatal or postpartum depression between groups, though rates of depression were lower than predicted (< 3%, whereas a 5% rate was predicted) in both groups, which suggests the study may have been underpowered to detect a difference [45•]. This (i.e., study size) reflects one of several ongoing issues in the evaluation of telemedicine and perinatal mental health, in addition to concerns surrounding patient acceptability of remote management and how to account appropriately for comorbid trauma and substance use in patients with perinatal mood disorders [46].
Though the academic community has issued calls for increased access to SUD services through telemedicine platforms [47••], the literature on the subject remains limited. A descriptive report from Patton and colleagues documents their experience in a perinatal medical home model during the pandemic, offering hybrid in person and telemedicine prenatal care and OUD treatment. Appointment attendance rates were noted to be higher under the hybrid model than they were prior to the pandemic and though not quantified, clinicians in the program noted that many patients preferred virtual visits, citing various deterrents associated with in-person appointments [48]. Limited quantitative data are offered through this account, however, and it is difficult to discern the model’s impact on the prenatal versus postpartum period. A 2020 trial from Guille and colleagues compared the standard in-person care delivery model for OUD in pregnancy and the postpartum period with a new virtual treatment model integrated into obstetric practices. There was no significant difference in postpartum treatment retention or neonatal abstinence syndrome between groups [49]. These limited data support a virtual option for SUD management in pregnancy and the postpartum period as a safe means of extending access to care without a decrement to care quality. Further research is needed to rigorously assess hybrid and telemedicine models against legacy in-person models of care.
Conclusion
At their core, both telemedicine and digital health solutions aim to augment, not replace, care relationships—between care providers and patients, clinicians and their colleagues, patients and their peers. Even as research continues to parse interventions that serve patients from those that do not, whether these tools advance intrapartum and postpartum care remains subject to the same contingencies present in other specialties and care contexts. These span from legal and regulatory hurdles to billing and reimbursement policies, from large scale patient health data stewardship to interoperability challenges with legacy systems, and from end-user troubleshooting to ongoing concerns surrounding health disparities [50•]. Overcoming these barriers relies, first and foremost, on the iterative and rigorous process of testing these technologies and their implementation in appropriate populations. Ongoing investment into the application and evaluation of telemedicine and digital health solutions throughout pregnancy should be prioritized.
Data Availability
No datasets were generated or analysed during the current study.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Weiner JP, Bandeian S, Hatef E, Lans D, Liu A, Lemke KW. In-person and telehealth ambulatory contacts and costs in a large US insured cohort before and during the COVID-19 pandemic. JAMA Network Open. 2021;4(3):e212618-e.
• Myrick KL, Mahar M, DeFrances CJ. Telemedicine use among physicians by physician specialty: United States, 2021. NCHS Data Brief. 2024;493:1–8. This report describes the use of telemedicine among physician sampled in the 2021 National Eletronic Health Records Survey.
•• Healy A, Davidson C, Allbert J, Bauer S, Toner L, Combs CA. Society for maternal-fetal medicine special statement: Telemedicine in obstetric; quality and safety considerations. Am J Obstet Gynecol. 2023;228(3):B8–17. This review discusses quality and safety considerations of telemedicine for pregnancy-related services. It describes the benefits of telemedicine compared to traditional in-person encounters in various domains of prenatal and postpartum care.
•• Society for Maternal-Fetal Medicine (SMFM); Kern-Goldberger AR, Malhotra T, Zera CA; SMFM Health Policy and Advocacy Committee. Society for Maternal-Fetal Medicine Special Statement: Utilizing telemedicine to address disparities in maternal-fetal medicine: a call to policy action. Am J Obstet Gynecol. 2024;230(5):B6–11. This paper reviewed the barriers to maternal fetal medicine case, the use of telemedicine to overcome the challenges, and advocacy priorities to help establish a telemedicine infrastructure.
Peahl AF, Smith RD, Moniz MH. Prenatal care redesign: Creating flexible maternity care models through virtual care. Am J Obstet Gynecol. 2020;223(3):389.e1-e10.
Kern-Goldberger AR, Srinivas SK. Telemedicine in obstetrics. Clin Perinatol. 2020;47(4):743–57.
• Atkinson J, Hastie R, Walker S, Lindquist A, Tong S. Telehealth in antenatal care: Recent insights and advances. BMC Med. 2023;21(1):332. This review explores the increased use telemedicine in prenatal care without adversely impacting clinical outcomes for mothers or babies.
• Wu KK, Lopez C, Nichols M. Virtual visits in prenatal care: An integrative review. J Midwifery Womens Health. 2022;67(1):39–52. This review explores the positive patient and provider experience with virtual visits in prenatal care.
Wechsler LR, Demaerschalk BM, Schwamm LH, Adeoye OM, Audebert HJ, Fanale CV, et al. Telemedicine quality and outcomes in stroke: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(1):e3–25.
Thomas EJ, Lucke JF, Wueste L, Weavind L, Patel B. Association of telemedicine for remote monitoring of intensive care patients with mortality, complications, and length of stay. JAMA. 2009;302(24):2671–8.
Barbash IJ, Sackrowitz RE, Gajic OO, Dempsey TM, Bell S, Millerman K, et al. Rapidly deploying critical care telemedicine across states and health systems during the Covid-19 pandemic. NEJM Catal Innov Care Deliv. 2020. https://catalyst.nejm.org/doi/abs/10.1056/CAT.20.0301.
• Sonenberg A, Mason DJ. Maternity care deserts in the US. JAMA Health Forum. 2023;4(1):e225541-e. This article discusses community models of perinatal care, workforce challenges, and policies to reduce maternity deserts.
Handley SC, Passarella M, Herrick HM, Interrante JD, Lorch SA, Kozhimannil KB, et al. Birth volume and geographic distribution of US hospitals with obstetric services from 2010 to 2018. JAMA Network Open. 2021;4(10):e2125373-e.
•• Theiler RN, Torbenson V, Schoen JC, Stegemann H, Heaton HA, Kozhimannil KB, et al. Virtual obstetric hospitalist support for obstetric emergencies and deliveries: The Mayo Clinic experience.Telemed J E Health. 2024. https://doi.org/10.1089/tmj.2023.0358. This paper describes the first 25 uses of an obstetric hospitalist telemedicine service for obstetrical emergencies in a low resource hospital setting.
Corey L, Vezina A, Gala RB. Using technology to improve women’s health care. Ochsner J. 2020;20(4):422–5.
O’Brien E, Rauf Z, Alfirevic Z, Lavender T. Women’s experiences of outpatient induction of labour with remote continuous monitoring. Midwifery. 2013;29(4):325–31.
•• Hamm RF, Shkolnik K, Keren N, Reches A, Purnell J, McCabe M, et al. Utilization of a wireless monitoring device to perform nonstress tests in high-risk pregnancies from home. Am J Obstet Gynecol. 2023;229(4):463–4. https://doi.org/10.1016/j.ajog.2023.06.012. This prospective cohort study demonstrated high clinical utility, safety profile, and good patient usability of a remote pregnancy monitoring system for remote non-stress tests in high risk pregnancies.
• Schwartz N, Mhajna M, Moody HL, Zahar Y, Shkolnik K, Reches A, et al. Novel uterine contraction monitoring to enable remote, self-administered nonstress testing. Am J Obstet Gynecol. 2022;226(4):554.e1–12. This prospective study demonstrated that a wireless remote pregnancy monitoring device can accurately assess uterine activity and detect contractions.
• Nir O, Dvir G, Galler E, Axelrod M, Farhi A, Barkai G, et al. Integrating technologies to provide comprehensive remote fetal surveillance: A prospective pilot study. Int J Gynecol Obstet. 2024;164(2):662–7. This pilot study showed feasibility with remote modified biophysical profile assessment amongst ten post-date pregnancies.
Hadar E, Wolff L, Tenenbaum-Gavish K, Eisner M, Shmueli A, Barbash-Hazan S, et al. Mobile self-operated home ultrasound system for remote fetal assessment during pregnancy. Telemed E-Health. 2021;28(1):93–101.
•• Waymouth M, James K, Uscher-Pines L. Advancing equity in maternal health with virtual doula care. JAMA Health Forum. 2024;5(1):e234833-e. This viewpoint explores the advantages and drawbacks of virtual doula services over traditional doula support and the role in reducing maternal morbidity and mortality rates and decreasing racial disparities.
•• Karwa S, Jahnke H, Brinson A, Shah N, Guille C, Henrich N. Association between doula use on a digital health platform and birth outcomes. Obstet Gynecol. 2024;143(2):175–83. https://doi.org/10.1097/AOG.0000000000005465. This retrospective cohort study evaluated the association between virtual doula appointments and birth experiences overall and by race. They found lower odds of cesarean birth and improved birth experiences with a virtual doula on the digital health platform among all users and among Black users.
• Cai F, McCabe M, Srinivas SK. A randomized trial assessing the impact of educational podcasts on personal control and satisfaction during childbirth. Am J Obstet Gynecol. 2023;228(5):592.e1–10. This randomized trial showed that a labor-related educational podcast increased patient satisfaction and labor agentry in low risk nulliparous patients undergoing induction of labor.
Duncan LG, Cohn MA, Chao MT, Cook JG, Riccobono J, Bardacke N. Benefits of preparing for childbirth with mindfulness training: A randomized controlled trial with active comparison. BMC Pregnancy Childbirth. 2017;17(1):140.
• Tully KP, Stuebe AM. Foreword: respectful, equitable, and supportive postpartum care. Clin Obstet Gynecol. 2022;65(3):538–49. https://doi.org/10.1097/GRF.0000000000000734. This foreword to a symposium on postpartum care highlights the importance of the postpartum period, the current culture of post-delivery care, and strategies to create systems for postnatal support through a health equity and reproductive justice lens.
Sardi L, Idri A, Redman LM, Alami H, Bezad R, Fernández-Alemán JL. Mobile health applications for postnatal care: review and analysis of functionalities and technical features. Comput Methods Programs Biomed. 2020;184:105114.
Cohen JL, Daw JR. Postpartum cliffs—missed opportunities to promote maternal health in the United States. JAMA Health Forum. 2021;2(12):e214164-e.
• Hoyert DL. Maternal mortality rates in the United States, 2021. NCHS Health E-Stats. 2023. https://doi.org/10.15620/cdc:124678. This report shows the maternal mortality rate for 2021 based on data from the National Vital Statistic System, showing increased rate overall and for Black women.
• Arias MP, Wang E, Leitner K, Sannah T, Keegan M, Delferro J, Iluore C, Arimoro F, Streaty T, Hamm RF. The impact on postpartum care by telehealth: a retrospective cohort study. Am J Obstet Gynecol MFM. 2022;4(3):100611. https://doi.org/10.1016/j.ajogmf.2022.100611. This retrospective cohort study showed that telehealth use during COVID-19 pandemic resulted in increased postpartum visit attendance and postpartum depression screening.
• Kumar NR, Arias MP, Leitner K, Wang E, Clement EG, Hamm RF. Assessing the impact of telehealth implementation on postpartum outcomes for Black birthing people. Am J Obstet Gynecol MFM. 2023;5(2):100831. This retrospective study showed that telehealth postpartum care reduced racial disparities in pospartum visit attendance.
Hirshberg A, Downes K, Srinivas S. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: A randomised clinical trial. BMJ Qual Saf. 2018;27(11):871–7.
Hirshberg A, Sammel MD, Srinivas SK. Text message remote monitoring reduced racial disparities in postpartum blood pressure ascertainment. Am J Obstet Gynecol. 2019;221(3):283–5.
•• Hirshberg A, Zhu Y, Smith-McLallen A, Srinivas SK. Association of a remote blood pressure monitoring program with postpartum adverse outcomes. Obstet Gynecol. 2023;141(6):1163–70. https://doi.org/10.1097/AOG.0000000000005197. This retrospective cohort study used administrative claims date to evaluate the association of a remote blood pressure monitoring program with adverse postpartum clinical outcomes in patients with a hypertensive disorder of pregnancy. They found that patients enrolled in a remote blood pressure monitoring program had less adverse outcomes in the first six months after delivery, lower number of emergency room visits and readmissions, and lower postpartum medical costs compared to control groups.
• Hauspurg A, Bryan S, Jeyabalan A, Davis EM, Hart R, Shirriel J, et al. Blood pressure trajectories through the first year postpartum in overweight or obese individuals following a hypertensive disorder of pregnancy. Hypertension. 2024;81(2):302–10. This analysis of data from a randomized trial showed that patients who had hypertension at 1 year postpartum had different blood pressure trajectory postpartum compared to those with blood pressure normalization.
Hauspurg A, Lemon L, Cabrera C, Javaid A, Binstock A, Quinn B, et al. Racial differences in postpartum blood pressure trajectories among women after a hypertensive disorder of pregnancy. JAMA Network Open. 2020;3(12):e2030815-e.
• Polsky S, Valent AM, Isganaitis E, Castorino K, O'Malley G, Beck SE, Gao P, Laffel LM, Brown FM, Levy CJ. Performance of the Dexcom G7 continuous glucose monitoring system in pregnant women with diabetes. Diabetes Technol Ther. 2024;26(5):307–12. https://doi.org/10.1089/dia.2023.0516. This study showed that real-time continuous glucose monitoring in pregnancy is safe and accurate.
Liang X, Fu Y, Lu S, Shuai M, Miao Z, Gou W, et al. Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: A prospective cohort study. The Lancet Regional Health – Western Pacific. 2023;39.
Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347–59.
•• Miremberg H, Yirmiya K, Rona S, Gonen N, Marom O, Pohol A, et al. Smartphone-based counseling and support platform and the effect on postpartum lactation: A randomized controlled trial. Am J Obstet Gynecol MFM. 2022;4(2):100543. This prospective trial showed that smartphone counseling and daily feedback on lactation via an app increased lactation rates after delivery compared to routine counseling.
Lewkowitz AK, López JD, Carter EB, Duckham H, Strickland T, Macones GA, et al. Impact of a novel smartphone application on low-income, first-time mothers’ breastfeeding rates: A randomized controlled trial. Am J Obstet Gynecol MFM. 2020;2(3):100143.
Griffin LB, López JD, Ranney ML, Macones GA, Cahill AG, Lewkowitz AK. Effect of novel breastfeeding smartphone applications on breastfeeding rates. Breastfeed Med. 2021;16(8):614–23.
Trost SL, Beauregard JL, Smoots AN, Ko JY, Haight SC, Moore Simas TA, et al. Preventing pregnancy-related mental health deaths: Insights from 14 US Maternal Mortality Review Committees, 2008–17. Health Aff (Millwood). 2021;40(10):1551–9.
• Bruzelius E, Martins SS. US trends in drug overdose mortality among pregnant and postpartum persons, 2017–2020. JAMA. 2022;328(21):2159–61. This study evaluates increases in overall and drug-specific overdose mortality among pregnant and postpartum persons before and during the COVID-19 pandemic.
Zhou C, Hu H, Wang C, Zhu Z, Feng G, Xue J, et al. The effectiveness of mHealth interventions on postpartum depression: A systematic review and meta-analysis. J Telemed Telecare. 2020;28(2):83–95.
• Nishi D, Imamura K, Watanabe K, Obikane E, Sasaki N, Yasuma N, et al. The preventive effect of internet-based cognitive behavioral therapy for prevention of depression during pregnancy and in the postpartum period (iPDP): A large scale randomized controlled trial. Psychiatry Clin Neurosci. 2022;76(11):570–8. This two-arm randomized controlled trial evaluated the effectiveness of an internet delivered cognitive behavioral therapy for preventing the onset of major depression in the third trimester and 3 months postpartum compared to general information. There was no difference in rates of perinatal or postpartum depression between groups.
Singla DR, Savel K, Dennis CL, Kim J, Silver RK, Vigod S, et al. Scaling up mental healthcare for perinatal populations: Is telemedicine the answer? Curr Psychiatry Rep. 2022;24(12):881–7.
•• Harper LM. Telehealth approaches to improve opioid use care in pregnancy. Clin Obstet Gynecol. 2021;64(2):352–65. https://doi.org/10.1097/GRF.0000000000000607. This case study reviews the use of telemedicine to treat opioid use disorder in pregnancy and reviews the barriers and possible solutions to increase access to pharmacotherapy via telehealth in this population.
Patton EW, Saia K, Stein MD. Integrated substance use and prenatal care delivery in the era of COVID-19. J Subst Abuse Treat. 2021;124:108273.
Guille C, Simpson AN, Douglas E, Boyars L, Cristaldi K, McElligott J, et al. Treatment of opioid use disorder in pregnant women via telemedicine: A nonrandomized controlled trial. JAMA Network Open. 2020;3(1):e1920177-e.
• Implementing telehealth in practice. Obstet. Gynecol. 2020;135(2):e73–9. https://doi.org/10.1097/AOG.0000000000003671. This Committee Opinion explores the increasing use of telehealth in obstetrics and gynecology and reviews considerations for implementation including licensing requirement and insurance coverage.
Author information
Authors and Affiliations
Contributions
AH and JS made substantial contributions to the conception or design of the work; drafted the work and revised it critically for important intellectual content, approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of Interests
The authors have no relevant financial or non-financial interests to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Stone, J.S., Hirshberg, A. Telemedicine and Digital Health Solutions in Intrapartum and Postpartum Care. Curr Obstet Gynecol Rep (2024). https://doi.org/10.1007/s13669-024-00394-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s13669-024-00394-x